Teladoc Health (TDOC) has jumped in Tuesday trading after an analyst team at Jefferies raised their price target from $8 to $10 per share. Josh Lipton and Josh Schafer cite the analyst note which points to Teladoc's ability to grow BetterHelp's web traffic flows.

For more expert insight and the latest market action, click here to watch this full episode of Market Domination.

This post was written by Luke Carberry Mogan.